Healthcare News and Headlines

Lung Cancer Molecular Testing Nears 70%, Still Falls Short of Universal Use: Christopher D'Avella, MD
NewsApr 10, 2026

Lung Cancer Molecular Testing Nears 70%, Still Falls Short of Universal Use: Christopher D'Avella, MD

Molecular profiling for newly diagnosed advanced non‑small cell lung cancer has risen from about 50% to roughly 70% before first‑line therapy, driven by stronger guideline awareness and more targetable mutations. However, testing gaps persist, especially when biopsies are performed without...

By AJMC (The American Journal of Managed Care)
PreCheck Pilot Program Structure
NewsApr 10, 2026

PreCheck Pilot Program Structure

The FDA’s PreCheck Pilot Program introduces a two‑phase pathway to speed the launch of new U.S. pharmaceutical manufacturing sites. Phase 1 delivers early, structured Pre‑Operational Reviews (POR) and builds a Type V Drug Master File that captures facility design, equipment qualification, and...

By FDA
Death by a Thousand Vendors: Solera Report Reveals The Hidden Costs of Digital Health
NewsApr 10, 2026

Death by a Thousand Vendors: Solera Report Reveals The Hidden Costs of Digital Health

Solera Health’s new report, based on a survey of 106 senior benefits leaders at firms with 1,000+ employees, reveals that 90% of large employers spend over $1 million annually on digital health solutions. The hidden operational expense of managing these fragmented...

By HIT Consultant
Oricell Therapeutics Secures $110 Million to Take on One of Oncology's Most Vexing Problems
NewsApr 10, 2026

Oricell Therapeutics Secures $110 Million to Take on One of Oncology's Most Vexing Problems

Oricell Therapeutics closed a pre‑IPO financing round exceeding $110 million, led by Vivo Capital and a slate of international investors. The capital will fund global clinical expansion and further development of its proprietary CAR‑T platform targeting solid tumors. Oricell’s lead candidate,...

By BioPharm International
University of Cincinnati Launches Clinical Trial to Test New Drug for Prosthetic Joint Infections
NewsApr 10, 2026

University of Cincinnati Launches Clinical Trial to Test New Drug for Prosthetic Joint Infections

The University of Cincinnati has begun enrolling patients in Peptilogics' RETAIN trial, a randomized, double‑blind study evaluating a novel peptide solution designed to penetrate biofilm in prosthetic joint infections (PJI). The trial will compare the peptide irrigant against a saline...

By News-Medical.Net
HEALTH HAZARDS: Patients ‘Left on Floors’ as Court Interdict Sought to Halt Dora Nginza Hospital Strike
NewsApr 10, 2026

HEALTH HAZARDS: Patients ‘Left on Floors’ as Court Interdict Sought to Halt Dora Nginza Hospital Strike

The Eastern Cape Department of Health has applied for an urgent court interdict to stop an unlawful strike at Dora Nginza Hospital, where staff walkouts left pregnant women and other patients unattended, some even lying on the floor. Video footage...

By Daily Maverick – Business
Plan for Remade ACIP Panel Adds Focus on Vaccine Safety, Matching Kennedy’s Push
NewsApr 10, 2026

Plan for Remade ACIP Panel Adds Focus on Vaccine Safety, Matching Kennedy’s Push

A federal judge recently halted most Trump-era appointments to the CDC’s Advisory Committee on Immunization Practices (ACIP), prompting the agency to draft a new charter that reshapes the panel’s composition and priorities. The revised charter emphasizes vaccine safety, mandating transparent...

By Endpoints News
5 Vaccines Under Development That Would Change the World As We Know It
NewsApr 10, 2026

5 Vaccines Under Development That Would Change the World As We Know It

Recent advances in vaccine technology are targeting five of the world’s most persistent health threats: HIV, tuberculosis, cancer, influenza, and coronaviruses. Early-phase trials show mRNA‑based germline‑targeting approaches can induce broadly neutralizing antibodies against HIV, while the M72/AS01E candidate achieved roughly...

By AJMC (The American Journal of Managed Care)
FDA Clears Investigational New Drug Application to Test sCAR-T Therapy for Autoimmune Conditions
NewsApr 10, 2026

FDA Clears Investigational New Drug Application to Test sCAR-T Therapy for Autoimmune Conditions

The FDA has cleared Calibr‑Skaggs Institute’s investigational new drug application to test its switchable CAR‑T therapy, CLBR001 + SWI019, in a phase 1 trial for autoimmune diseases. The study will enroll patients with myositis, systemic sclerosis, lupus and rheumatoid arthritis, aiming to demonstrate...

By News-Medical.Net
Health‑coverage Decisions in Retirement Can Shape when and How Federal Retirees Tap Their Money
NewsApr 10, 2026

Health‑coverage Decisions in Retirement Can Shape when and How Federal Retirees Tap Their Money

Federal retirees must navigate FEHB coverage abroad, the eight‑month Medicare Part B special enrollment period, and decisions about their Thrift Savings Plan. Overseas, some FEHB plans like Blue Cross Blue Shield process claims locally, while others require out‑of‑pocket payment and reimbursement,...

By Federal News Network
Bioanalytical Method Validation for Biomarkers
NewsApr 10, 2026

Bioanalytical Method Validation for Biomarkers

The U.S. Food and Drug Administration issued final Level 2 guidance (Docket FDA‑2017‑D‑6821) on bioanalytical method validation for biomarkers. It outlines the evidentiary standards for measuring biomarker concentrations in clinical trials and non‑clinical studies. The guidance applies to IND, NDA, BLA, ANDA,...

By FDA
Alpheus Medical Advances to Phase 2b Testing of Experimental Brain Cancer Therapy
NewsApr 10, 2026

Alpheus Medical Advances to Phase 2b Testing of Experimental Brain Cancer Therapy

Alpheus Medical has enrolled 10 patients in a Phase 2b randomized trial of its Porphyrin Metabolite Activation (PoMA) therapy for newly diagnosed glioblastoma. PoMA uses a tumor‑selective drug activated by low‑intensity diffuse ultrasound to treat the entire affected brain hemisphere,...

By BioPharm International
Hospital M&A Rebounds After 2025 Lull
NewsApr 10, 2026

Hospital M&A Rebounds After 2025 Lull

Hospital and health‑system M&A rebounded in Q1 2026, with 22 announced deals—the highest first‑quarter total in six years. The quarter’s transacted revenue hit $14.5 billion, buoyed by several mega‑mergers exceeding $1 billion in annual revenue. Divestitures dominated, accounting for 15 of the...

By Healthcare Dive (Industry Dive)
Bayer Pharma Executive Predicts US-Europe Price Spreads Will Narrow
NewsApr 10, 2026

Bayer Pharma Executive Predicts US-Europe Price Spreads Will Narrow

Bayer's chief operating officer for pharmaceuticals warned that the long‑standing price gap between the United States and European markets will shrink sharply. He attributes the change to the Trump administration's push for “most‑favored‑nation” (MFN) pricing agreements, which compel manufacturers to...

By Endpoints News
UFC Renews Partnership With HSS to Boost Fighter Recovery
NewsApr 10, 2026

UFC Renews Partnership With HSS to Boost Fighter Recovery

UFC has renewed its partnership with Hospital for Special Surgery (HSS) under a new multiyear agreement, extending the collaboration that began in 2017. HSS will maintain its integrated role at the UFC Performance Institute, adding an enhanced presence at the...

By Muscle & Fitness
What General Atlantic’s $3B TEAM Bet Says About Home-Based Care’s Evolution
NewsApr 10, 2026

What General Atlantic’s $3B TEAM Bet Says About Home-Based Care’s Evolution

General Atlantic acquired home‑care platform TEAM Services for roughly $3 billion, a deal reported at a 10‑times multiple. The purchase highlights a shift toward tech‑enabled, infrastructure‑heavy providers that blend direct care with payroll and Medicaid financial‑management services. TEAM’s portfolio, bolstered by...

By Home Health Care News
Waitlist Drops, but 717 Still Waiting for Gynaecology Care in Hawke’s Bay
NewsApr 10, 2026

Waitlist Drops, but 717 Still Waiting for Gynaecology Care in Hawke’s Bay

Health New Zealand reports 717 patients still awaiting gynecology care in Hawke’s Bay, down from over 900 last year, as weekly new consultations rise to 39. Waiting periods over a year have fallen to 113, yet many women with chronic conditions...

By NZ Herald – Business
Active HIMSS Communities Drive Healthcare Industry Progress
NewsApr 10, 2026

Active HIMSS Communities Drive Healthcare Industry Progress

HIMSS’s global community of committees, workgroups and task forces, led by senior thought leaders, is translating strategic plans into measurable change across the health‑care sector. By pooling expertise in business intelligence, operations and workforce development, the organization accelerates digital transformation,...

By Healthcare Finance News (HIMSS Media)
HIMSS Attendance Makes for Conversation, Collaboration, Commitment
NewsApr 10, 2026

HIMSS Attendance Makes for Conversation, Collaboration, Commitment

The annual HIMSS Global Conference continues to serve as a catalyst for face‑to‑face dialogue among health‑IT professionals. Tammy Kwiatkoski notes that 75% of HIMSS members participate in one of its 22 specialized communities, underscoring deep engagement. Attendees cite the event’s...

By Healthcare IT News (HIMSS Media)
New Research Sheds Light on U.S. State Variations in Longevity Improvements
NewsApr 10, 2026

New Research Sheds Light on U.S. State Variations in Longevity Improvements

A new study analyzing CDC mortality data reveals that gains in U.S. life expectancy have diverged sharply across states over the past decade. While states such as Massachusetts and Colorado have added more than two years to average longevity since...

By Bioengineer.org
State Associations Urge CMS to Forgo Potential National Hospice Enrollment Moratorium
NewsApr 10, 2026

State Associations Urge CMS to Forgo Potential National Hospice Enrollment Moratorium

A coalition of state hospice associations—including Florida, North Carolina, and South Carolina—has written to CMS urging it to reject a proposed national moratorium on new hospice provider enrollments. They argue that a blanket freeze would restrict legitimate hospice growth in...

By Hospice News
Replimune’s Advanced Melanoma Drug Rebuffed by FDA for Second Time
NewsApr 10, 2026

Replimune’s Advanced Melanoma Drug Rebuffed by FDA for Second Time

Replimune’s oncolytic immunotherapy RP1, aimed at unresectable advanced cutaneous melanoma, was rejected by the FDA for a second time on April 6, 2026. The agency’s complete response letter said the data, derived from a single‑arm trial, were insufficient to demonstrate substantial effectiveness,...

By BioSpace
A Multi-Society Effort Is Driving Imaging Interoperability Across Healthcare
NewsApr 10, 2026

A Multi-Society Effort Is Driving Imaging Interoperability Across Healthcare

Digital pathology is expanding rapidly, but labs face a critical hurdle: making whole‑slide images interoperable across vendors and institutions. A joint webinar by the Digital Pathology Association, the College of American Pathologists, and the Society for Imaging Informatics in Medicine...

By Healthcare Innovation
Health Care Roundup: Market Talk
NewsApr 10, 2026

Health Care Roundup: Market Talk

AstraZeneca's Q1 outlook hints at higher spending to launch camizestrant for breast cancer and baxdrostat for hypertension, while Farxiga inventory reductions could pressure sales as generics enter the U.S. market. Analysts also expect strong contributions from oncology staples Imfinzi, Tagrisso...

By Wall Street Journal — Markets
BMS and Oxford BioTherapeutics Join Forces in TCE Discovery Pact
NewsApr 10, 2026

BMS and Oxford BioTherapeutics Join Forces in TCE Discovery Pact

Bristol Myers Squibb has entered a discovery partnership with Oxford BioTherapeutics to develop T‑cell engager (TCE) therapies for solid tumours. BMS will pay an undisclosed upfront fee to access OBT’s OGAP‑Verify platform, while OBT will design and deliver pre‑clinical candidates....

By Pharmaceutical Technology (GlobalData)
PVL After TTVR Linked to Much Lower Survival Rate, Fewer Clinical Benefits
NewsApr 10, 2026

PVL After TTVR Linked to Much Lower Survival Rate, Fewer Clinical Benefits

A new analysis of the TRIPLACE registry shows that paravalvular leak (PVL) after transcatheter tricuspid valve replacement (TTVR) dramatically worsens outcomes. Moderate or greater PVL was present in 6.1% of nearly 400 patients and drove one‑year all‑cause mortality to 39.7%,...

By Cardiovascular Business
Babies Born to Lower-Income Families Face Worse Birth Outcomes
NewsApr 10, 2026

Babies Born to Lower-Income Families Face Worse Birth Outcomes

A new study of 380,000 U.S. births from 2012‑2022 links family income directly to newborn health. Mothers below 200% of the federal poverty line experienced higher rates of preterm delivery and low birthweight, with the low‑birthweight gap widening sharply over...

By Futurity
Evolving Approaches to CKD-MBD Address Cardiovascular and Fracture Risk
NewsApr 10, 2026

Evolving Approaches to CKD-MBD Address Cardiovascular and Fracture Risk

A new review from the University of Florida highlights that patients with chronic kidney disease (CKD) and end‑stage kidney disease (ESKD) continue to suffer high cardiovascular and fracture mortality despite traditional phosphate‑focused treatment. The authors argue that targeting novel pathways...

By AJMC (The American Journal of Managed Care)
DHA Offers $300M for Health IT Deployment Support
NewsApr 10, 2026

DHA Offers $300M for Health IT Deployment Support

The Defense Health Agency (DHA) has issued an indefinite‑delivery, indefinite‑quantity (IDIQ) solicitation for up to $300 million to support global deployments of its electronic health‑record platform MHS GENESIS and associated medical‑device integrations. The one‑year contract, with possible annual extensions, seeks commercial services...

By Healthcare IT News (HIMSS Media)
Other News to Note for April 10, 2026
NewsApr 10, 2026

Other News to Note for April 10, 2026

BioWorld’s April 10 briefing highlights three notable developments. Jiangsu and Shanghai Hengrui have patented novel Nav1.8 sodium‑channel blockers, a class of compounds with potential for pain and inflammatory disease therapies. New hematopoietic stem‑cell research links chronic inflammation to early‑stage leukemia, deepening...

By BioWorld (Citeline) – Featured Feeds
CDER Manual of Policies & Procedures | MAPP
NewsApr 10, 2026

CDER Manual of Policies & Procedures | MAPP

The FDA’s Center for Drug Evaluation and Research (CDER) has posted ten updated Manual of Policies and Procedures (MAPPs) covering drug safety, generic drug review, new drug assessment, and public outreach. The revisions, dated between July 2025 and January 2026,...

By FDA
2026 Future Leaders Awards: Final Entry Deadline Approaching
NewsApr 10, 2026

2026 Future Leaders Awards: Final Entry Deadline Approaching

The 2026 Future Leaders Awards are entering their final entry phase, with submissions due by 11:59 pm CDT on April 15, 2026. The program spotlights high‑performing employees 40 years or younger who are shaping home health, home care, and related sectors. Winners receive press‑release recognition,...

By Home Health Care News
China Biotech’s CRISPR Therapy Suggests US Drugmakers Will Face Competition
NewsApr 10, 2026

China Biotech’s CRISPR Therapy Suggests US Drugmakers Will Face Competition

A Chinese biotech firm used CRISPR‑Cas9 to edit blood stem cells in five beta thalassemia patients, eliminating their need for regular transfusions. The ex‑vivo therapy reactivates fetal hemoglobin and showed durable engraftment with no serious adverse events over a year...

By Endpoints News
Using Menstrual Blood-Derived Particles to Treat Osteoarthritis
NewsApr 10, 2026

Using Menstrual Blood-Derived Particles to Treat Osteoarthritis

Lithuanian researchers have demonstrated that extracellular vesicles (EVs) harvested from menstrual‑blood‑derived mesenchymal stromal cells can stimulate cartilage regeneration in vitro, offering a cell‑free therapy for osteoarthritis. The EVs improved chondrocyte function and extracellular matrix synthesis even in cartilage cells taken...

By Phys.org – Nanotechnology
Autonomous Coding Tech Boosts Revenue 5.1% at Mercyhealth
NewsApr 10, 2026

Autonomous Coding Tech Boosts Revenue 5.1% at Mercyhealth

Mercyhealth, a 200‑location health system in Wisconsin and Illinois, deployed Arintra’s autonomous coding platform within its Epic EHR to address a surge to over 130,000 monthly charts. The AI‑driven tool automates routine coding, freeing coders for complex, high‑value work while...

By Healthcare IT News (HIMSS Media)
Apple Unveiled a New High-End Market Opportunity This Week
NewsApr 10, 2026

Apple Unveiled a New High-End Market Opportunity This Week

Apple’s Studio Display XDR earned FDA clearance for its Medical Imaging Calibration feature, opening a new niche in the medical‑device market. The $2,899 calibrated display can replace traditional radiology workstations that cost $15,000 or more, offering a lower‑cost, Apple‑integrated solution....

By Computerworld – IT Leadership
When Steam Reliability Is Non-Negotiable, Hospitals Trust the Miura EX Boiler
NewsApr 10, 2026

When Steam Reliability Is Non-Negotiable, Hospitals Trust the Miura EX Boiler

The Miura America EX Series dual‑fuel steam boiler delivers full steam in under five minutes, a stark contrast to the hour‑long warm‑up of conventional fire‑tube units. It generates 99%+ saturated steam through a three‑stage separation process, meeting the stringent purity...

By FM Link
Oricell Closes a ‘Pre-IPO’ Megaround to Aim CAR-T at Solid Tumors
NewsApr 10, 2026

Oricell Closes a ‘Pre-IPO’ Megaround to Aim CAR-T at Solid Tumors

Oricell Therapeutics, a Shanghai‑based biotech, closed a pre‑IPO financing round of more than $110 million to accelerate its CAR‑T programs targeting solid tumors, starting with liver cancer. Its lead candidate, Ori‑C101, targets the GPC3 protein and has shown a 60% response...

By BioPharma Dive
Thai Authorities Push for Mandatory Medical Insurance for Scooter Crashes
NewsApr 10, 2026

Thai Authorities Push for Mandatory Medical Insurance for Scooter Crashes

Thai health officials are considering mandatory medical insurance for tourists who rent scooters, after foreign patients generate roughly $3.1 million in unpaid hospital costs each year. In Phuket alone, Vachira Phuket Hospital reported a $300,000 loss from unpaid treatments, including a...

By TravelAwaits
Navigating the European Union’s AI and Health Data Framework
NewsApr 10, 2026

Navigating the European Union’s AI and Health Data Framework

The EU is consolidating GDPR, the AI Act, and the European Health Data Space (EHDS) into a unified framework that treats health‑focused AI as high‑risk, imposing strict data provenance, validation and post‑deployment oversight. Cross‑border transfers of health data now carry...

By Atlantic Council – All Content
Sun Pharma Shares Down 4 per Cent on Reports of Overtures for US-Based Organon
NewsApr 10, 2026

Sun Pharma Shares Down 4 per Cent on Reports of Overtures for US-Based Organon

Sun Pharmaceutical Industries’ shares fell about 4% to ₹1,654.70 (≈$20) after media reports that the company is close to a $12 billion bid for U.S. women’s‑health firm Organon. The deal would be Sun’s largest ever acquisition, adding Organon’s $6.2 billion 2025 revenue,...

By The Hindu BusinessLine – Markets
Vivatides Gets $54M; Wegovy Drops Cold Chain in EU; Gilead Takes Kymera Option
NewsApr 10, 2026

Vivatides Gets $54M; Wegovy Drops Cold Chain in EU; Gilead Takes Kymera Option

Vivatides Therapeutics announced a $54 million Series A round to accelerate its pre‑clinical siRNA and antisense oligonucleotide programs, with Sequoia Capital leading the investment. In Europe, Novo Nordisk confirmed that its obesity drug Wegovy will drop the costly cold‑chain requirement, simplifying distribution. Meanwhile,...

By Endpoints News
AHA Names Its Preferred Cybersecurity Provider
NewsApr 10, 2026

AHA Names Its Preferred Cybersecurity Provider

The American Hospital Association (AHA) has appointed Rubrik as its Preferred Cybersecurity Provider, giving roughly 5,000 member hospitals access to Rubrik’s cyber‑resilience tools and a breach‑recovery playbook. The designation is part of the AHA’s Preferred Cybersecurity & Risk Provider Program...

By Healthcare Finance News (HIMSS Media)
Hospital Expenses Grew Twice as Fast as Hospital Prices in 2025, Finds AHA
NewsApr 10, 2026

Hospital Expenses Grew Twice as Fast as Hospital Prices in 2025, Finds AHA

The American Hospital Association’s 2026 Costs of Caring report shows hospital expenses surged 7.5% in 2025, outpacing price growth by more than double. Workforce costs, which account for about 60% of total spending, rose 5.6%, while supplies and drugs jumped...

By FM Link
The Virtual Pivot: Reformulating Nursing Care Through Remote Health Monitoring
NewsApr 10, 2026

The Virtual Pivot: Reformulating Nursing Care Through Remote Health Monitoring

Healthcare leaders are redefining nursing care models by integrating remote patient monitoring (RPM) and telehealth into a hybrid, virtual‑first framework. The "Virtual Pivot" expands nurses’ reach beyond bedside walls, turning surveillance tasks into digital data streams that alert clinicians to...

By HealthTech Magazines – AI in Healthcare
States' Lawsuit Against HHS Cuts Moves Forward After Court Win
NewsApr 10, 2026

States' Lawsuit Against HHS Cuts Moves Forward After Court Win

A federal judge in Rhode Island rejected Health and Human Services Secretary Robert F. Kennedy Jr.'s bid to dismiss a lawsuit filed by 19 states and the District of Columbia. The states challenge a March 2025 directive to drastically cut HHS staff and dissolve...

By Healthcare Finance News (HIMSS Media)
PDUFA and BsUFA Quarterly Hiring Updates
NewsApr 10, 2026

PDUFA and BsUFA Quarterly Hiring Updates

The FDA published its quarterly hiring updates for fiscal years 2023‑2027 under PDUFA VII and BsUFA III. FY2023 staffing was almost complete—CBER filled 99% of its 132 positions and CDER 90% of 77—while FY24 reached only 71% of 79 targeted FTEs. FY25...

By FDA
FDA/Center for Research on Complex Generics (CRCG) Workshop on Bioequivalence Innovations for Generic Oral Products: Biowaivers, Bridging, and Development for...
NewsApr 10, 2026

FDA/Center for Research on Complex Generics (CRCG) Workshop on Bioequivalence Innovations for Generic Oral Products: Biowaivers, Bridging, and Development for...

On May 5‑6, 2026, the FDA’s Center for Research on Complex Generics hosted a two‑day workshop in Rockville, MD to explore innovative bioequivalence (BE) strategies for generic oral drugs. The agenda covered biowaivers, bridging studies, and development pathways for oncology agents,...

By FDA
South Africa’s Air Mercy Service Marks 60 Years of Aero-Medical Operations
NewsApr 10, 2026

South Africa’s Air Mercy Service Marks 60 Years of Aero-Medical Operations

South Africa’s Air Mercy Service (AMS) marked its 60th anniversary, highlighting six decades of aero‑medical transport, rescue missions, and Flying Doctor outreach for remote communities. Based at Cape Town International Airport, AMS collaborates with government, international partners, and health stakeholders...

By Business Airport International